Franklin, and all:
Happy to offer what I know. First of all, I hope that some of us were able to get in on that little run this week (from .12 to .20). Alas, all my spare change is tied up in other plays that are agonizingly slow to unfold. I'd have flipped this thing a few times for some decent money by now.
What's happening at PDTI: Things are moving along slowly, and the resultant lack of heat has allowed the stock to drift lower. I will say in defense of the folks at PDTI, at least they aren't over-hyping (gg). Some issues with the potential of this one would already be crowing multi-million dollar futures. Mike Leum and the folks at PDTI have chosen to remain low-key until everything is lined up.
I also note that when the ask price nearly doubles on fewer than 20,000 shares, the float must be tightening.
What I know: everything is in place for PDTK to move ahead with Biotrack. Perhaps some of the contract wording has yet to be hammered, perhaps there are a few of the original subscribers who have yet to be contact on the latest buyout, perhaps Hale-Bopp put them behind. I also have heard, but cannot confirm yet, that the FDA either has approved, is close to approving another application of the technology -- meaning another new market.
Bottom line (from my opinion only:) At .20 ask, this stock is tight and a good deal. Flip it while you can, if that's your style. Otherwise accumulate and wait for summer. It should be fun.
Hope everyone survived the spring storms,
Chick in soggy NC |
